Thursday September 26, 2024 9:45am - 10:30am EDT
Speakers
Senior Manager, Health Equity, Diversity, Equity, and Inclusion, and University Programs, Myriad Genetics
I am a dedicated Diversity, Equity, Inclusion, and Belonging (DEIB) professional with nearly a decade of experience navigating the intersections of for-profit, non-profit, and government healthcare settings. My career has been marked by a commitment to driving systematic change and...
Read More →
Chief Medical Officer, Sumitomo Pharma America
Dr. Jatin Shah has served as Chief Medical Officer – Oncology of Sumitomo Pharma America since April 1, 2024. Prior to this role, he served as the Chief Oncology Development Officer since the Company’s formation in 2023, and as Executive Vice President, Chief Medical Officer and...
Read More →
Vice President, Head of Clinical Sites, Data Management & Quality, Merck
Jennifer Sheller joined Merck in 2017 as an Associate Vice President, Clinical Operations. She is currently the Global Head of Monitoring Excellence, Site Partnerships / Engagement and Clinical Trial Diversity. Jennifer’s background includes a bachelor’s degree in Molecular Biology...
Read More →
Director of Clinical Innovation and Optimization, Jazz Pharmaceuticals
Keith Ho is the Director of Clinical Innovation and Optimization within the clinical operations organization and the co-lead for the Trial Inclusiveness and Diversity Initiative at Jazz Pharmaceuticals. In his role, his objective is to develop an enterprise-level trial inclusiveness...
Read More →
Thursday September 26, 2024 9:45am - 10:30am EDT